Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$596,804
+$239,794 QoQ
Shares Held
244,592
+0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,232,542,246 across 191 Biotechnology names. ALLO ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in ALLO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $596,804 | 244,592 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $357,010 | 244,528 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $430,137 | 201,943 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $495,915 | 177,113 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $787,644 | 338,045 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $845,008 | 189,040 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $610,846 | 190,295 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $426,653 | 134,591 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $552,543 | 111,176 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,992,624 | 808,224 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $4,033,071 | 641,188 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,325,535 | 770,883 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,942,239 | 1,047,565 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,187,761 | 1,008,536 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,662,756 | 714,662 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,813,030 | 381,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $745,392 | 28,581 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $859,449 | 24,347 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $738,875 | 29,274 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,159,318 | 30,743 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,477,117 | 34,496 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||